关注
Oleksandr Ekshyyan
Oleksandr Ekshyyan
Senior NGS Analytical Scientist, Spark Therapeutics Inc
在 sparktx.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Neuronal apoptosis in neurodegeneration
M Okouchi, O Ekshyyan, M Maracine, TY Aw
Antioxidants & redox signaling 9 (8), 1059-1096, 2007
2792007
Apoptosis: a key in neurodegenerative disorders
O Ekshyyan, TY Aw
Current neurovascular research 1 (4), 355-371, 2004
1592004
Differential effects of superoxide dismutase isoform expression on hydroperoxide-induced apoptosis in PC-12 cells
EK Pias, OY Ekshyyan, CA Rhoads, J Fuseler, L Harrison, TY Aw
Journal of Biological Chemistry 278 (15), 13294-13301, 2003
1522003
Association between human papilloma virus/Epstein–Barr virus coinfection and oral carcinogenesis
R Jiang, O Ekshyyan, T Moore‐Medlin, X Rong, S Nathan, X Gu, F Abreo, ...
Journal of Oral Pathology & Medicine 44 (1), 28-36, 2015
1152015
Apoptosis in acute and chronic neurological disorders
O Ekshyyan, TY Aw
Front Biosci 9 (1567–1576), 1567-1576, 2004
972004
Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma
O Ekshyyan, Y Rong, X Rong, KM Pattani, F Abreo, G Caldito, JKS Chang, ...
Molecular cancer therapeutics 8 (8), 2255-2265, 2009
822009
Serum biomarkers in head and neck squamous cell cancer
NM Kaskas, T Moore-Medlin, GB McClure, O Ekshyyan, JA Vanchiere, ...
JAMA otolaryngology–head & neck surgery 140 (1), 5-11, 2014
652014
Decreased susceptibility of differentiated PC12 cells to oxidative challenge: relationship to cellular redox and expression of apoptotic protease activator factor-1
O Ekshyyan, TY Aw
Cell Death & Differentiation 12 (8), 1066-1077, 2005
652005
Curcumin inhibits UV radiation–induced skin cancer in SKH-1 mice
J Phillips, T Moore-Medlin, K Sonavane, O Ekshyyan, J McLarty, ...
Otolaryngology--Head and Neck Surgery 148 (5), 797-803, 2013
632013
Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients
C Clark, S Shah, L Herman‐Ferdinandez, O Ekshyyan, F Abreo, X Rong, ...
The Laryngoscope 120 (6), 1159-1165, 2010
622010
Topical curcumin‐based cream is equivalent to dietary curcumin in a skin cancer model
K Sonavane, J Phillips, O Ekshyyan, T Moore-Medlin, J Roberts Gill, ...
Journal of skin cancer 2012 (1), 147863, 2012
502012
Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced‐stage head and neck squamous cell carcinoma
O Ekshyyan, GM Mills, T Lian, N Amirghahari, X Rong, ...
Head & neck 32 (12), 1619-1628, 2010
352010
Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models
O Ekshyyan, TN Moore-Medlin, MC Raley, K Sonavane, X Rong, ...
BMC cancer 13, 1-9, 2013
282013
Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells
O Ekshyyan, AR Khandelwal, X Rong, T Moore-Medlin, X Ma, ...
American journal of translational research 8 (11), 4822, 2016
252016
Enhanced systemic bioavailability of curcumin through transmucosal administration of a novel microgranular formulation
B Latimer, O Ekshyyan, N Nathan, T Moore-Medlin, X Rong, X Ma, ...
Anticancer research 35 (12), 6411-6418, 2015
232015
Efficacy and comparative effectiveness of sirolimus as an anticancer drug
M Hu, O Ekshyyan, LH Ferdinandez, X Rong, G Caldito, CAO Nathan
The Laryngoscope 121 (5), 978-982, 2011
222011
Dual PI3K/mTOR inhibitors: does p53 modulate response?
O Ekshyyan, A Anandharaj, CAO Nathan
Clinical Cancer Research 19 (14), 3719-3721, 2013
182013
Photopreventive effect and mechanism of AZD4547 and curcumin C3 complex on UVB-induced epidermal hyperplasia
AR Khandelwal, X Rong, T Moore-Medlin, O Ekshyyan, F Abreo, X Gu, ...
Cancer Prevention Research 9 (4), 296-304, 2016
152016
Local and systemic Curcumin C3 complex inhibits 4NQO-induced oral tumorigenesis via modulating FGF-2/FGFR-2 activation
AR Khandelwal, T Moore-Medlin, O Ekshyyan, X Gu, F Abreo, ...
American Journal of Cancer Research 8 (12), 2538, 2018
112018
Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer
V Mehta, T Moore-Medlin, JM Flores, X Ma, O Ekshyyan, CAO Nathan
Oncotarget 8 (41), 70907, 2017
102017
系统目前无法执行此操作,请稍后再试。
文章 1–20